Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
Sales | 393 | 677 | 91 | 263 | 116 |
Cost of Goods | 109 | N/A | N/A | N/A | N/A |
Gross Profit | 284 | 570 | 91 | 263 | 116 |
Operating Expenses | 2,587 | 2,821 | 2,766 | 2,381 | 1,879 |
Operating Income | -2,194 | -2,144 | -2,675 | -2,118 | -1,763 |
Interest Expense | 315 | 329 | 315 | 317 | 317 |
Other Income | 98 | 121 | 132 | 127 | 214 |
Pre-tax Income | -2,411 | -2,352 | -2,858 | -2,308 | -1,866 |
Net Income Continuous | -2,411 | -2,352 | -2,858 | -2,308 | -1,866 |
Net Income | $-2,411 | $-2,352 | $-2,858 | $-2,308 | $-1,866 |
EPS Basic Total Ops | -1,125.00 | -1,125.00 | -1,375.00 | -1,125.00 | -875.00 |
EPS Basic Continuous Ops | -1,141.57 | -1,120.58 | -1,357.33 | -1,096.13 | -901.69 |
EPS Diluted Total Ops | -1,125.00 | -1,125.00 | -1,375.00 | -1,125.00 | -875.00 |
EPS Diluted Continuous Ops | -1,141.57 | -1,120.58 | -1,357.33 | -1,096.13 | -901.69 |
EBITDA(a) | $-1,983 | $-1,930 | $-2,478 | $-1,952 | $-1,651 |